Gene · 8542
Papers3,519
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 3,519
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proteomic profiling of circulating plasma exosomes reveals novel biomarkers of Alzheimer's disease. | Alzheimers Res Ther | 2022 | 36471423 | PubTator, text mining | PubMed |
| A Case of COVID-Associated Nephropathy (COVAN). | Cureus | 2022 | 36465729 | PubTator, text mining | PubMed |
| Machine learning models to predict in-hospital mortality in septic patients with diabetes. | Front Endocrinol (Lausanne) | 2022 | 36465642 | PubTator, text mining | PubMed |
| Small molecules in the treatment of COVID-19. | Signal Transduct Target Ther | 2022 | 36464706 | PubTator, text mining | PubMed |
| Characterization of a proteomic profile associated with organ dysfunction and mortality of sepsis and septic shock. | PLoS One | 2022 | 36459524 | PubTator, text mining | PubMed |
| Chronic kidney disease (CKD) and associated risk in rural South Africa: a population-based cohort study. | Wellcome Open Res | 2022 | 36457874 | PubTator, text mining | PubMed |
| Next-generation proteomics of serum extracellular vesicles combined with single-cell RNA sequencing identifies MACROH2A1 associated with refractory COVID-19. | Inflamm Regen | 2022 | 36451245 | PubTator, text mining | PubMed |
| [Acute kidney injury and nephrotic syndrome secondary to COVID-19-associated focal segmental glomerulosclerosis]. | Nefrologia | 2022 | 36447643 | PubTator, text mining | PubMed |
| A pilot study for treatment of severe COVID-19 pneumonia by aerosolized formulation of convalescent human immune plasma exosomes (ChipEXO™). | Front Immunol | 2022 | 36439138 | PubTator, text mining | PubMed |
| COVID-19 and the Kidney: Recent Advances and Controversies. | Semin Nephrol | 2022 | 36435682 | PubTator, text mining | PubMed |
| Unveiling sex-based differences in Parkinson's disease: a comprehensive meta-analysis of transcriptomic studies. | Biol Sex Differ | 2022 | 36414996 | PubTator, text mining | PubMed |
| IgA vasculitis with nephritis (Henoch-Schönlein purpura) after COVID-19: A case series and review of the literature. | Nefrologia (Engl Ed) | 2022 | 36400685 | PubTator, text mining | PubMed |
| Apolipoprotein L1 Genotypes and the Association of Urinary Potassium Excretion with CKD Progression. | Clin J Am Soc Nephrol | 2022 | 36400568 | PubTator, text mining | PubMed |
| Genetic Modifiers of Sickle Cell Disease. | Hematol Oncol Clin North Am | 2022 | 36400533 | PubTator, text mining | PubMed |
| CTLA4 Gene Polymorphism and its Association with Disease Occurrence, Clinical Manifestations, Serum Markers and Cytokine Levels in SLE Patients from North India. | Indian J Dermatol | 2022 | 36386077 | PubTator, text mining | PubMed |
| Codon Usage and Context Analysis of Genes Modulated during SARS-CoV-2 Infection and Dental Inflammation. | Vaccines (Basel) | 2022 | 36366382 | PubTator, text mining | PubMed |
| The Search for Associations of Serum Proteins with the Presence of Unstable Atherosclerotic Plaque in Coronary Atherosclerosis. | Int J Mol Sci | 2022 | 36361589 | PubTator, text mining | PubMed |
| Protein prediction models support widespread post-transcriptional regulation of protein abundance by interacting partners. | PLoS Comput Biol | 2022 | 36356032 | PubTator, text mining | PubMed |
| Genetic Engineering of Talaromyces marneffei to Enhance Siderophore Production and Preliminary Testing for Medical Application Potential. | J Fungi (Basel) | 2022 | 36354950 | PubTator, text mining | PubMed |
| Tip-Variant Focal Segmental Glomerulosclerosis in a Patient With Primary Hypothyroidism: A Case Report. | Cureus | 2022 | 36348899 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8542/papers?page=39